Pheast Raises $76M in Series A Funding to Train the Immune System to Feast on Cancer

/PRNewswire/ -- Pheast Therapeutics, a company developing novel checkpoint therapies to fight cancer, today announced it has raised $76 million in Series A...

Related Keywords

New York ,United States ,Alexandria ,Al Iskandariyah ,Egypt ,London ,City Of ,United Kingdom ,Jacob Volgelstein ,Amira Barkal ,Ravi Majeti ,Steven Gillis ,Irving Weissman ,Roy Maute ,George Petrocheilos ,Forty Seven Inc ,Stanford University ,Innate Immune System ,Fight Cancer ,Catalio Capital Management ,Alexandria Venture Investments ,Forty Seven ,Principal Founder ,Scientific Director ,Irv Weissman ,Managing Director ,Capital Management ,General Partnership ,